Cargando…
Utility of tolcapone in fluctuating Parkinson’s disease
Fluctuating Parkinson’s disease (PD) represents a clinical management challenge. The primary utility of levodopa in patients with PD is moderated by the “wearing off” phenomena seen with long-term use. COMT inhibitors slow down the rapid metabolism of levodopa, resulting in a more-sustained response...
Autores principales: | Stocchi, Fabrizio, De Pandis, Maria Francesca |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699640/ https://www.ncbi.nlm.nih.gov/pubmed/18046910 |
Ejemplares similares
-
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
por: Artusi, Carlo Alberto, et al.
Publicado: (2021) -
The efficacy of homemade tolcapone in the treatment of patients with Parkinsons disease
por: Zhang, Pei-Lan, et al.
Publicado: (2018) -
Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease
por: Casanova, Yaquelyn, et al.
Publicado: (2022) -
Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson’s disease
por: Truong, Daniel D
Publicado: (2009) -
Effects of tolcapone and bromocriptine on cognitive stability and flexibility
por: Cameron, Ian G. M., et al.
Publicado: (2018)